LYTIX BIOPHARMA ASA
Signals
- Driftsunderskudd 2025 Siste driftsresultat er negativt (−64,0 mill kr).
- Nylig endring 2026-04-16 Selskapsform registrert 2026-04-16.
LYTIX BIOPHARMA ASA is registered as a public limited company in Oslo, Oslo with organisation number 985889635. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2003 and has 8 registered employees. Registered share capital is NOK 7.7m, divided into 76900005 shares. The company's stated purpose is: “Utvikling, markedsføring og salg av farmasøytiske og bioteknologiske produkter, samt dertil hørende virksomhet. Selskapet kan ha eierinteresser i foretak innen samme eller tilstøtende bransjer.”.
Former names: LYTIX BIOPHARMA AS
Key figures · 2025
Financial health · 2025
Who owns LYTIX BIOPHARMA ASA?
LYTIX BIOPHARMA ASA has 20+ registered shareholders:
- JAKOB HATTELAND HOLDING AS 10.1%
- CITIBANK, N.A. 7.2%
- TAJ HOLDING AS 6.6%
- SATURN INVEST AS 6.6%
- SKANDINAVISKA ENSKILDA BANKEN AB 3.8%
- LYR INVEST AS 3.6%
- BRØDRENE KARLSEN HOLDING AS 3.3%
- PER STRAND EIENDOM AS 3.0%
- 3T PRODUKTER HOLDING AS 2.6%
- LYSNES INVEST AS 2.1%
- NORDNET LIVSFORSIKRING AS 2.1%
- YNNI INVEST AS 2.0%
- HIFO INVEST AS 1.9%
- KVASSHØGDI AS 1.9%
- LTH INVEST AS 1.3%
- BELVEDERE AS 1.3%
- DRAGESUND INVEST AS 1.0%
- Per Ove Løkke Pettersen 0.9%
- Arun Vohra 0.9%
- CARE HOLDING AS 0.9%
Frequently asked questions about LYTIX BIOPHARMA ASA
Who owns LYTIX BIOPHARMA ASA?
JAKOB HATTELAND HOLDING AS is the largest registered owner, with 10.1%.
Who is the general manager of LYTIX BIOPHARMA ASA?
Øystein Rekdal is registered as general manager of LYTIX BIOPHARMA ASA.
Where is LYTIX BIOPHARMA ASA based?
LYTIX BIOPHARMA ASA has its business address in Oslo.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 03.10.2026.